Xencor Licenses Technology To Australian Firm
socalTECH
APRIL 17, 2013
Monrovia, California-based biotherapeutics technology developer Xencor said Tuesday that it has licensed its Xtend technology to an Australian firm. Xencor and CSL Limited said they are in a technology license agreement, which will provide CSL access ot its technology, for use with CSL''s monoclonal antibodies.
Let's personalize your content